Predicting the risk of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy: Validating the CAMD and AASL scores in China

BACKGROUND: We aimed to validate the predictive value of the cirrhosis, age, male sex, and diabetes (CAMD) score and age, albumin, sex, and liver cirrhosis (AASL) score for chronic hepatitis B (CHB) patients, treated with nucleos(t)ide analogues (NUCs) in Northeast China. METHODS: From January 2009...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuai, Liu, Bingwei, Fan, Xuemei, Gao, Yang, Hong, Mingqi, Xu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752533/
https://www.ncbi.nlm.nih.gov/pubmed/35170433
http://dx.doi.org/10.4103/sjg.sjg_527_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752533/
https://www.ncbi.nlm.nih.gov/pubmed/35170433
http://dx.doi.org/10.4103/sjg.sjg_527_21

Ejemplares similares